Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel

Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.

NCT00209690 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer

NCT00578201 ·Status: COMPLETED ·Phase: PHASE2

A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

NCT03914443 ·Status: COMPLETED ·Phase: PHASE1

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

NCT01704690 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients

NCT03002064 ·Status: UNKNOWN ·Phase: PHASE3

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

NCT02459457 ·Status: COMPLETED ·Phase: PHASE3

Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma

NCT03964753 ·Status: RECRUITING ·Phase: PHASE2

Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.

NCT00209716 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Induction FLOT With CROSS CRT for Esophageal Cancer

NCT04028167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

NCT04390958 ·Status: UNKNOWN ·Phase: PHASE2

Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

NCT01998347 ·Status: WITHDRAWN ·Phase: PHASE3

TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma

NCT06401447 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

NCT05594914 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

NCT05740995 ·Status: RECRUITING

A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

NCT01183559 ·Status: COMPLETED ·Phase: PHASE1

Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma

NCT02384811 ·Status: UNKNOWN ·Phase: PHASE2

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

NCT03985046 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

NCT00021320 ·Status: COMPLETED ·Phase: PHASE2

Radiation Dose Escalation in Esophageal Cancer

NCT03082586 ·Status: COMPLETED ·Phase: NA

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

NCT02213497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Induction Chemotherapy for Locally Advanced Esophageal Cancer

NCT03110926 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

NCT00938470 ·Status: COMPLETED ·Phase: PHASE2

Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

NCT00368329 ·Status: TERMINATED ·Phase: PHASE1

Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.

NCT01248299 ·Status: TERMINATED ·Phase: PHASE2

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients

NCT01258192 ·Status: COMPLETED ·Phase: PHASE2